Last reviewed 2026-04-22 · How we verify

Novo Helisen Depot, Phostal

Medical University of Lodz · FDA-approved active Biologic

Novo Helisen Depot, Phostal is a Biologic drug developed by Medical University of Lodz. It is currently FDA-approved. Also known as: Novo Helisen Depot.

Novo Helisen Depot is a depot formulation of helisen (likely a peptide or protein therapeutic) designed for sustained release and prolonged therapeutic effect.

At a glance

Generic name	Novo Helisen Depot, Phostal
Also known as	Novo Helisen Depot
Sponsor	Medical University of Lodz
Modality	Biologic
Phase	FDA-approved

Mechanism of action

The exact molecular mechanism is not well-documented in widely available sources. Helisen appears to be a therapeutic agent formulated as a depot injection to provide extended duration of action, reducing dosing frequency. Phostal may refer to a phosphate salt formulation or related pharmaceutical form.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Novo Helisen Depot, Phostal CI brief — competitive landscape report
Novo Helisen Depot, Phostal updates RSS · CI watch RSS
Medical University of Lodz portfolio CI

Frequently asked questions about Novo Helisen Depot, Phostal

What is Novo Helisen Depot, Phostal?

Novo Helisen Depot, Phostal is a Biologic drug developed by Medical University of Lodz.

How does Novo Helisen Depot, Phostal work?

Novo Helisen Depot is a depot formulation of helisen (likely a peptide or protein therapeutic) designed for sustained release and prolonged therapeutic effect.

Who makes Novo Helisen Depot, Phostal?

Novo Helisen Depot, Phostal is developed and marketed by Medical University of Lodz (see full Medical University of Lodz pipeline at /company/medical-university-of-lodz).

Is Novo Helisen Depot, Phostal also known as anything else?

Novo Helisen Depot, Phostal is also known as Novo Helisen Depot.

What development phase is Novo Helisen Depot, Phostal in?

Novo Helisen Depot, Phostal is FDA-approved (marketed).

Manufacturer: Medical University of Lodz — full pipeline
Also known as: Novo Helisen Depot
Compare: Novo Helisen Depot, Phostal vs similar drugs
Pricing: Novo Helisen Depot, Phostal cost, discount & access